All News

Pharmacists help women with type 1 diabetes plan pregnancy, adjust insulin and tech, and stay safe postpartum with personalized guidance.

In Texas community pharmacies, researchers assess the communication concordance between pharmacists and patients during medication counseling.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

MiniMed Flex is a smaller, screenless, and phone-controlled insulin automation that shows how pharmacists boost AID success for patients with diabetes.

Annie Lambert, PharmD, BCSCP, discusses pharmacies’ regulation and compliance needs when it comes to dispensing compounded GLP-1s.

The new parameter combines waist circumference, hypertension status, and glycated hemoglobin to determine insulin resistance.

FDA approves icotrokinra as a first-line systemic treatment of plaque psoriasis with a targeted oral peptide for adults and pediatric patients.

Many states are pushing pharmacies to move beyond the traditional dispensing role into more robust clinical care.

Combined with nutritional interventions, semaglutide also demonstrates greater weight loss compared with dulaglutide.

CDC researchers investigate pneumococcal disease cases and intervention strategies within a North Carolina correctional facility from June 14 to July 30, 2024.

The health care landscape for metabolic liver disease is undergoing a shift, and pharmacists are being positioned at the forefront of this therapeutic revolution.

From proposed transparency rules to Medicare price negotiation programs, the stakes are high for pharmacy reimbursement and the sustainability of independent practices.

The FDA clears secukinumab for patients 12 years and older with tough hidradenitis suppurativa, offering weight-based IL‑17A biologic relief and new guidance on screening and safety.

Annie Lambert, PharmD, BCSCP, discusses the key approaches to ensuring safe and effective dispensing of compounded GLP-1 medications.

From patient perspectives on acceptability, researchers assess the impact of pharmacist-led point-of-care testing services in rural Tennessee communities.

Remote hub model in New Zealand upskills pharmacists to launch automated insulin delivery faster, expanding equitable access for type 1 diabetes.

This landmark decision follows previous approvals for adults 60 years and older, as well as those aged 50 to 59 years at increased risk.

Researchers investigate PCV25 developments and potential use of the vaccine among adults who are healthy and naïve to the pneumococcal vaccine.

Eli Lilly flags unknown impurities in compounded tirzepatide with B12 as FDA targets misleading GLP-1 marketing.

Amid increased use of artificial intelligence across pharmacy, researchers assess pharmacists’ propensity to trust the emerging automated technology.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

US pharmacists can prescribe contraception through streamlined pharmacy care, expanding access; supporting maternity deserts; and improving women’s health.

FDA approves Wellcovorin for rare FOLR1 cerebral folate deficiency, spotlighting real-world evidence, dosing goals, and key drug-interaction risks.

Highlighting 'prone to abuse' and adverse effects as the driver of this bill, Senator Hawley aims to reverse an FDA decision made over 25 years ago.

A study finds prior-authorization bans do not boost buprenorphine retention for patients on private insurance.

Mark Cuban Cost Plus Drug Company challenges pharmacy benefit managers' opacity, expands affordable drug access, and supports community pharmacies.

Drug shortages remain one of the most persistent challenges in pharmacy practice, but emerging technologies like AI are beginning to shift the landscape for pharmacies and public health as a whole.